Best deals to access real time data! |
Small Cap Pro
Monthly Subscription
for only
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
Ultimate Trader
Monthly Subscription
for only
|
VAT not included
|
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Mount Tam Biotechnologies, Inc. (PC) | MNTM | OTC BB | Common Stock |
Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded ![]() |
|
---|---|---|---|---|---|---|---|---|
0.00 | 0.0% | 0.015 | 0.00 | 0.00 | 0.00 | 0.015 | 19:00:00 |
Bid Price | Ask Price | Spread | Spread % | News | |
---|---|---|---|---|---|
0.01 | 0.015 | 0.005 | 33.33% | - | - |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 0.00 | USD |
Mount TAM Biotechnologies, Inc. Financials
Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
---|---|---|---|---|---|
$ 835.66k | 55.71M | $ -150.32k | - | - | 15.43M |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | $ - | 0.00% | - | - |
Mount TAM Biotechnologies, Inc. News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MNTM Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
3 Months | 0.0184 | 0.0799 | 0.0059 | 0.0323338 | 225,977 | -0.0034 | -18.48% |
6 Months | 0.02755 | 0.0799 | 0.0059 | 0.0319274 | 137,567 | -0.01255 | -45.55% |
1 Year | 0.022 | 0.0799 | 0.0056 | 0.0312547 | 81,363 | -0.007 | -31.82% |
3 Years | 0.31 | 0.80 | 0.0003 | 0.1242803 | 47,909 | -0.295 | -95.16% |
5 Years | 0.72 | 1.48 | 0.0003 | 0.20884 | 36,798 | -0.705 | -97.92% |
Mount TAM Biotechnologies, Inc. Description
Mount Tam Biotechnologies is a specialty biopharmaceutical company formed to develop, optimize and bring to market leading medical compounds to better the health and well-being of millions of people who have been affected by autoimmune diseases. The organization's most advanced product, TAM-01, focuses on the treatment of systemic lupus erythematosus (SLE) - the most common form of lupus. |